Policy Influence NPC engages in policy-relevant research on value of patient access to innovative medicines and informs policy discussions through media, congressional testimony, and leading voices, presenting an opportunity to offer policy analytics, payer impact studies, and communication support for policy positions.

Clinical Outcomes Recent partnerships with academic institutions and a focus on disparities in prescription drug utilization suggest demand for real-world evidence, health economics, and outcomes research services to support value-based discussions and payer negotiations.

Executive Leadership New senior leadership in research and policy indicates a strategic expansion and potential for high-level collaboration, enabling co-authored studies, think-tank style briefs, and joint grant proposals with pharmaceutical and life sciences stakeholders.

Engagement Spotlight Active participation in major oncology forums like ASCO signals opportunities to offer targeted research, policy briefing materials, and data visualizations tailored for oncology payers, providers, and patient access advocates.

Funding Profile Mid-size revenue with a focused mission and valuable policy research capabilities positions NPC as a partner for funded research programs, thought-leadership content, and consulting on coverage and reimbursement policy for innovative medicines.